193 related articles for article (PubMed ID: 35663536)
1. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.
Sims TT; Colbert LE; Klopp AH
J Immunother Precis Oncol; 2021 May; 4(2):72-78. PubMed ID: 35663536
[TBL] [Abstract][Full Text] [Related]
2. Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.
Kaelin EA; Skidmore PT; Łaniewski P; Holland LA; Chase DM; Herbst-Kralovetz MM; Lim ES
mSystems; 2022 Apr; 7(2):e0006422. PubMed ID: 35343798
[TBL] [Abstract][Full Text] [Related]
3. Cervicovaginal Microbiome after Cervical Intraepithelial Neoplasia Treatment. A Protocol for Systematic Review and Meta-Analysis.
Janicka-Kośnik M; Sarecka-Hujar B; Jakiel G; Słabuszewska-Jóźwiak A
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501639
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer.
Curty G; de Carvalho PS; Soares MA
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905652
[TBL] [Abstract][Full Text] [Related]
5. Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia.
Kumari S; Bhor VM
Microb Pathog; 2021 Mar; 152():104780. PubMed ID: 33545325
[TBL] [Abstract][Full Text] [Related]
6. Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion.
Ravilla R; Coleman HN; Chow CE; Chan L; Fuhrman BJ; Greenfield WW; Robeson MS; Iverson K; Spencer H; Nakagawa M
Integr Cancer Ther; 2019; 18():1534735419893063. PubMed ID: 31833799
[TBL] [Abstract][Full Text] [Related]
7. Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN).
Finzer P; Küppers V; Griesser H
Geburtshilfe Frauenheilkd; 2023 Aug; 83(8):1017-1021. PubMed ID: 37588255
[TBL] [Abstract][Full Text] [Related]
8. Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model.
Spurgeon ME; Townsend EC; Blaine-Sauer S; McGregor SM; Horswill M; den Boon JA; Ahlquist P; Kalan L; Lambert PF
mBio; 2024 May; ():e0093324. PubMed ID: 38742830
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Human Papillomavirus Status and the Cervicovaginal Microbiome in Cervical Cancer.
Nguyen HDT; Le TM; Lee E; Lee D; Choi Y; Cho J; Park NJ; Chong GO; Seo I; Han HS
Microorganisms; 2023 May; 11(6):. PubMed ID: 37374919
[TBL] [Abstract][Full Text] [Related]
10. Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study.
Zhou FY; Zhou Q; Zhu ZY; Hua KQ; Chen LM; Ding JX
Ann Transl Med; 2020 Nov; 8(21):1408. PubMed ID: 33313153
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.
Głowienka-Stodolak M; Bagińska-Drabiuk K; Szubert S; Hennig EE; Horala A; Dąbrowska M; Micek M; Ciebiera M; Zeber-Lubecka N
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254888
[TBL] [Abstract][Full Text] [Related]
12. Cervicovaginal Microbiome and Urine Metabolome Paired Analysis Reveals Niche Partitioning of the Microbiota in Patients with Human Papilloma Virus Infections.
Chorna N; Romaguera J; Godoy-Vitorino F
Metabolites; 2020 Jan; 10(1):. PubMed ID: 31952112
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
Schiffman MH; Bauer HM; Hoover RN; Glass AG; Cadell DM; Rush BB; Scott DR; Sherman ME; Kurman RJ; Wacholder S
J Natl Cancer Inst; 1993 Jun; 85(12):958-64. PubMed ID: 8388478
[TBL] [Abstract][Full Text] [Related]
14. The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.
Kudela E; Liskova A; Samec M; Koklesova L; Holubekova V; Rokos T; Kozubik E; Pribulova T; Zhai K; Busselberg D; Kubatka P; Biringer K
EPMA J; 2021 Jun; 12(2):199-220. PubMed ID: 34194585
[TBL] [Abstract][Full Text] [Related]
15. Cervicovaginal microbiota dysbiosis correlates with HPV persistent infection.
Qingqing B; Jie Z; Songben Q; Juan C; Lei Z; Mu X
Microb Pathog; 2021 Mar; 152():104617. PubMed ID: 33207260
[TBL] [Abstract][Full Text] [Related]
16. IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia.
Tjiong MY; Schegget JT; Tjiong-A-Hung SP; Out TA; Van Der Vange N; Burger MP; Struyk L
Int J Gynecol Cancer; 2000 Jul; 10(4):296-304. PubMed ID: 11240690
[TBL] [Abstract][Full Text] [Related]
17. Modulating the microbiome to improve therapeutic response in cancer.
McQuade JL; Daniel CR; Helmink BA; Wargo JA
Lancet Oncol; 2019 Feb; 20(2):e77-e91. PubMed ID: 30712808
[TBL] [Abstract][Full Text] [Related]
18. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment.
Kustrimovic N; Bombelli R; Baci D; Mortara L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675055
[TBL] [Abstract][Full Text] [Related]
19. The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina Population.
Mancilla V; Jimenez NR; Bishop NS; Flores M; Herbst-Kralovetz MM
J Epidemiol Glob Health; 2024 Feb; ():. PubMed ID: 38407720
[TBL] [Abstract][Full Text] [Related]
20. Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment.
Łaniewski P; Cui H; Roe DJ; Chase DM; Herbst-Kralovetz MM
NPJ Precis Oncol; 2020; 4():22. PubMed ID: 32802959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
